Sign Up to like & get recommendations! 0
Published in 2022 at "American Journal of Ophthalmology Case Reports"
DOI: 10.1016/j.ajoc.2022.101425
Abstract: Purpose To report two cases of metastatic neuroendocrine tumors masquerading as primary ocular disease. Observations Case 1 is a 38-year-old man who was referred with subacute onset diplopia and fluctuating ptosis suggestive of myasthenia gravis.… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000003792
Abstract: ABSTRACT Somatostatin receptor-targeted α-therapy using α-emitter 225Ac-labeled somatostatin analogs has been suggested as a treatment option in advanced metastatic neuroendocrine tumors (NETs) failing treatment with β-emitters, such as 177Lu or 90Y. Thymus NETs are rare… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Neuroendocrinology"
DOI: 10.1111/jne.13092
Abstract: The annual prevalence of metastatic neuroendocrine tumours (mNETs) is rising, leading to significant healthcare costs. The present study aimed to describe healthcare resource use (HRU) and the corresponding costs among patients with mNETs, according to… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Neuroendocrinology"
DOI: 10.1111/jne.13210
Abstract: The aim of this study was to evaluate the efficacy and safety of 177Lu‐DOTATATE therapy in advanced metastatic disease. A retrospective analysis of 395 patients (180 female, 215 males, mean age 62) with progressive metastatic… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-240042
Abstract: In this manuscript, we describe a rare case of neuroendocrine tumour metastatic to the testicle, presenting with testicular mass as an isolated symptom. We describe the investigations and management leading us to this uncommon histological… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Case Reports in Oncology"
DOI: 10.1159/000529730
Abstract: Abstract Lenvatinib is a tyrosine kinase inhibitor that is being used to treat neuroendocrine tumors based on the success shown in the TALENT trial. There are two documented cases of lenvatinib-induced pancreatitis in patients being… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "International Journal of Surgical Pathology"
DOI: 10.1177/10668969221095267
Abstract: Background. Metastasis to parotid gland occurs mostly from skin cancers of the head and neck region. Metastatic neuroendocrine tumors to the parotid gland are rare and not well studied so far. In this study, we… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Korean Circulation Journal"
DOI: 10.4070/kcj.2018.0367
Abstract: https://e-kcj.org A 41-year-old female with history of benign carcinoid tumor status post nephrectomy presents with left upper quadrant abdominal pain. Computed tomography (CT) demonstrated a large retroperitoneal mass with biopsy revealing a low-grade neuroendocrine tumor.… read more here.